Who invested in Allay Therapeutics?
Allay Therapeutics's investors include Lightstone Ventures, ClavystBio, WTT Investment, New Enterprise Associates and Temasek Holdings, and 10 more on record. Lightstone Ventures led its latest round.

United States · Series D startup
Funding summaryUpdated 26 Oct 2026
$58Mraised across 1 round since 2025, from 2 sources
Reported by Firms' own news pages and 1 otherSEC filing: $45M sold, first sale Jan 2025
Allay Therapeutics's investors include Lightstone Ventures, ClavystBio, WTT Investment, New Enterprise Associates and Temasek Holdings, and 10 more on record. Lightstone Ventures led its latest round.
Allay Therapeutics has raised $58M across 1 round since 2025.
Allay Therapeutics's most recent round was a Series D of $58M in Jun 2025, led by Lightstone Ventures.
Its most recent round, $58M in Jun 2025, is also its largest on record.
Allay Therapeutics's first round on record, in Jun 2025, was backed by Lightstone Ventures, ClavystBio and WTT Investment and 12 others.
Allay Therapeutics's latest named round is a Series D, in Jun 2025.
Allay Therapeutics is based in the United States.
Lightstone Ventures led the Series D in 2025.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.